BETH LOPEZ: Open Payments
NPI 1073626016 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,515 in 134 payments from 20 companies in 2025. Trend: 2023 $2,936 · 2024 $3,140 · 2025 $2,515
Food & beverage: $2,515
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 22 | $449 |
| GENZYME CORPORATION | 14 | $308 |
| Novartis Pharmaceuticals Corporation | 12 | $285 |
| Regeneron Healthcare Solutions, Inc. | 9 | $236 |
| ABBVIE INC. | 17 | $233 |
| UCB, Inc. | 13 | $177 |
| Lilly USA, LLC | 5 | $121 |
| PFIZER INC. | 7 | $119 |
| Incyte Corporation | 6 | $104 |
| Janssen Biotech, Inc. | 5 | $91 |
Products named: DUPIXENT, ADBRY, SKYRIZI, COSENTYX, Bimzelx, ANZUPGO, EBGLYSS, OPZELURA.
Industry payments across AZ — which companies pay providers there.
